Prophylaxis Covid-19
Showing 26 - 50 of >10,000
COVID-19, Viral Respiratory Illnesses Trial in United States (Nitazoxanide, Placebo, Vitamin Super B-Complex)
Terminated
- COVID-19
- Viral Respiratory Illnesses
- Nitazoxanide
- +2 more
-
Kissimmee, Florida
- +3 more
Jun 28, 2022
Cancer, COVID, Coronavirus Infection Trial in SAo Paulo (Placebo, Ivermectin, Losartan)
Terminated
- Cancer
- +2 more
- Placebo
- +2 more
-
SAo Paulo, BrazilInstituto do Cancer do Estado de Sao Paulo
Aug 5, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Covid19 Trial in Tucumán (Ivermectin, Placebo)
Completed
- Covid19
- Ivermectin
- Placebo
-
Tucumán, ArgentinaSI.PRO.SA, Ministerio de Salud Pública
Dec 1, 2021
COVID-19 Trial in Cairo (EgyVax Vaccine Candidate, Placebo)
Recruiting
- COVID-19
- EgyVax Vaccine Candidate
- Placebo
-
Cairo, EgyptCairo University Hospitals (Al-Manial Specialized University Hos
Feb 6, 2022
TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted
Withdrawn
- Solid Organ Transplant Recipients
- Blood and saliva samplings
-
Lyon, France
- +1 more
Aug 29, 2022
COVID-19, SARS-CoV 2 Trial in Sioux Falls (Hydroxychloroquine, Vitamin D)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine
- Vitamin D
-
Sioux Falls, South DakotaSanford Health
Dec 8, 2021
Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)
Completed
- Covid19
- SARS-CoV Infection
-
Johannesburg, Gauteng, South Africa
- +1 more
Jun 6, 2022
COVID-19, Pharmacokinetics, Safety Trial in Pittsburgh (Q-Griffithsin, Placebo)
Recruiting
- COVID-19
- +2 more
- Q-Griffithsin
- Placebo
-
Pittsburgh, PennsylvaniaIngrid Macio
Mar 31, 2022
Coronavirus Disease 2019 (COVID-19) Trial in United Kingdom, United States (AZD7442 (tixagevimab [AZD8895] + cilgavimab
Active, not recruiting
- Coronavirus Disease 2019 (COVID-19)
- AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
-
Birmingham, Alabama
- +15 more
Nov 7, 2022
EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in
Recruiting
- COVID-19
-
Abu Dhabi, United Arab Emirates
- +1 more
Jul 20, 2022
Respiratory Viral Infection, Antiviral Treatment, COVID-19 Trial in Los Angeles (Mitoquinone/mitoquinol mesylate)
Recruiting
- Respiratory Viral Infection
- +2 more
- Mitoquinone/mitoquinol mesylate
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 3, 2022
COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))
Recruiting
- COVID-19, SARS-CoV-2
- AZD5156
- +2 more
-
Buenos Aires, Argentina
- +20 more
Jan 12, 2023
COVID-19 Trial in Albuquerque (Hydroxychloroquine)
Terminated
- COVID-19
-
Albuquerque, New MexicoUniversity of New Mexico Health Sciences Center
Feb 10, 2022
COVID-19 Prevention Trial in Louisville (Q-Griffithsin, Placebo)
Completed
- COVID-19 Prevention
- Q-Griffithsin
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Apr 28, 2022
COVID, Coronavirus Infection Trial in New York (Chloroquine, Placebo oral tablet)
Terminated
- COVID
- Coronavirus Infection
- Chloroquine
- Placebo oral tablet
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jan 10, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
COVID-19 Trial in Amman (HCQ & AZ)
Withdrawn
- COVID-19
- HCQ & AZ
-
Amman, JordanKing Hussein Cancer Center
Oct 23, 2021
Covid19, SARS-CoV 2, Coronavirus Infection Trial in Madrid (Melatonin 2mg, Placebo oral tablet)
Completed
- Covid19
- +2 more
- Melatonin 2mg
- Placebo oral tablet
-
Madrid, SpainHospital Universitario La Paz
Nov 22, 2021
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Tucumán (Ivermectin / Iota-Carrageenan)
Completed
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Ivermectin / Iota-Carrageenan
-
Tucumán, ArgentinaSI.PRO.SA, Ministerio de Salud Pública
Feb 22, 2021
COVID-19 Prevention Trial in Louisville (Q-Griffithsin 3.0, Q-Griffithsin 6.0)
Recruiting
- COVID-19 Prevention
- Q-Griffithsin 3.0
- Q-Griffithsin 6.0
-
Louisville, KentuckyUniversity of Louisville Clinical Trials Unit
Jun 28, 2022